RE:RE:RE:The News ReleasePandora wrote: swyint123888 wrote: I emailed the company to remove the misleading NR and restate it.....I hope they do it on their own before the governing bodies make them do it.....this is pathetic to say the least.....asking 9 now......do you think serious real investors are going to stand for these childesh games.....18.3 million what a joke
It's all in how you frame it. Stockwatch got the same news and issued it this way:
Datametrex AI loses $1.35-million in Q2 2022
2022-08-26 09:26 ET - News Release
Mr. Marshall Gunter reports
DATAMETREX REPORTS OVER $18.3M REVENUE IN THE SECOND QUARTER
Datametrex AI Ltd. has released its financial results for the second quarter. Datametrex has filed on SEDAR its financial statements and related management discussion and analysis (MD&A) for the quarterly results ending June 30, 2022 (Q2 2022).
Q1 2022 financial summary
The company's financial performance experienced a significant increase in its IT services revenue and is currently working with several companies to expand and grow its AI (artificial intelligence) and technology sectors.
The company reported revenue of over $18-million, earnings before interest, taxes, depreciation and amortization (EBITDA) of $1,431,035 and adjusted EBITDA of $3,265,906 for six months ended June 30, 2022. The company bared a non-cash expense of $1,834,871 for option issuance and depreciation and amortization of $1,255,173. Management believes adjusted EBITDA, $3,265,906, is the true reflection of operations within the last six months. The cash balance remains strong. The company used $934,116 to exercise the normal course issuer bid to increase return to the company's shareholders.
"Our 2022 second quarter results reflect a strong increase in our IT services as we expand our core AI and IT services to companies globally. We look forward to further expanding these services through MediCall and DMEVS. We are proud to be one of the small cap stocks to maintain a strong cash balance and are thrilled to see our share buy back program gain traction," said Marshall Gunter, chief executive officer of the company.
The following financial information from the financial results ending June 30, 2022, and management discussion and analysis are available for review on SEDAR.
Please refer to the Q2 2022 filing in its entirety, which is available under Datametrex's profile at SEDAR.
Oops, dropped off half the items: try it again:
Datametrex AI loses $1.35-million in Q2 2022
2022-08-26 09:26 ET - News Release
Mr. Marshall Gunter reports
DATAMETREX REPORTS OVER $18.3M REVENUE IN THE SECOND QUARTER
Datametrex AI Ltd. has released its financial results for the second quarter. Datametrex has filed on SEDAR its financial statements and related management discussion and analysis (MD&A) for the quarterly results ending June 30, 2022 (Q2 2022).
Q1 2022 financial summary
The company's financial performance experienced a significant increase in its IT services revenue and is currently working with several companies to expand and grow its AI (artificial intelligence) and technology sectors.
The company reported revenue of over $18-million, earnings before interest, taxes, depreciation and amortization (EBITDA) of $1,431,035 and adjusted EBITDA of $3,265,906 for six months ended June 30, 2022. The company bared a non-cash expense of $1,834,871 for option issuance and depreciation and amortization of $1,255,173. Management believes adjusted EBITDA, $3,265,906, is the true reflection of operations within the last six months. The cash balance remains strong. The company used $934,116 to exercise the normal course issuer bid to increase return to the company's shareholders.
"Our 2022 second quarter results reflect a strong increase in our IT services as we expand our core AI and IT services to companies globally. We look forward to further expanding these services through MediCall and DMEVS. We are proud to be one of the small cap stocks to maintain a strong cash balance and are thrilled to see our share buy back program gain traction," said Marshall Gunter, chief executive officer of the company.
The following financial information from the financial results ending June 30, 2022, and management discussion and analysis are available for review on SEDAR.
Please refer to the Q2 2022 filing in its entirety, which is available under Datametrex's profile at SEDAR.
Outlook
The company continues to build its EV operations as testing trials begin for the Smart EV Charger. Seven (7) commercial properties were also secured by the Company in North Vancouver to install DM EVS chargers and EV charging stations. The Company also continues to work on telehealth operations with Medi-Call. With the launch of the app on all iOS and Android devices, DM is focused on building subscribers and expanding Medi-Call with diversified services to fit patient needs.
Additionally, the Company is working towards building its core business in AI and IT technology and expanding globally to provide AI services to companies to broader the Company's scope outside of government AI work. All required documents to graduate from the TSX Venture Exchange have been submitted to uplist to the TSX main board.